Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
25 August 2022 | Story Rulanzen Martin | Photo Rulanzen Martin
Vency Mupupa, Jessica Lynne and Dr Nadine Lake
From the left: Vency Mupupa, Jessica Lynn and Dr Nadine Lake.

Creating residences and other spaces that adapt to change without it being forced is a process that requires time, patience, and nurturing. Through recent engagements with Jessica Lynn, a transgender activist from the Kinsey Institute in the United States, the Centre for Gender and Africa Studies (CGAS) and the Housing and Residence Affairs (HRA) division at the University of the Free State (UFS) are committing to creating dialogue and engagements that will foster gender-, transgender- and LGBTQI-positive attitudes for residences on and off the UFS campuses. 

Most of the advocacy and educating work envisaged by the CGAS and HRA did not materialise due to the COVID-19 pandemic. “There are issues coming to the forefront amongst the student community in terms of gender identity and gender fluidity on all three UFS campuses. It is visible that these issues exist, but they are not being discussed,” said Dr Nadine Lake of the CGAS. She added that the Centre would like the UFS to continue addressing issues like acceptance, inclusion, and diversity, but to also focus on gender identity and not just on race.  

Inclusive living spaces: The seed has been planted 

“We reached out to Housing and Residence Affairs (HRA) around creating more education and advocacy for students and staff within HRA around transgender identity specifically, but then also gender,” Lake said. According to Vency Mupupa, Senior Officer: Accommodation Services at HRA, the seed for a broad-based gender awareness project within on-campus residences started in 2019, when HRA was tasked with conducting research into inclusive housing. 

“The focus is not only on transgender people but the LGBTQI community at large. We are starting small, but eventually it will affect the larger student population,” Mupupa said. 

She emphasised that the focus is not only on students in residences but also on staff within HRA and the residences. “We have 25 000 students, and on-campus residences can only accommodate around 6 000 students, so it is a drop in the ocean, but if we can educate everyone else the space will move away from being unaccepting and become more inclusive.” 

Transgender awareness breaks down walls 

Referencing her own experiences, Lynn, who is a transgender woman, said that advocating for gender awareness is all about creating safe spaces for people to be their authentic self. “It is a very closeted feeling,” she said. “When I transitioned, I experienced a lot of bad things, and I wanted to use my experience to help educate others so that are not trapped the same way I was. There is a very small percentage of people worldwide who identify as transgender… It is not like there are no transgendered people here, it is just that they are scared of coming out.” 

Universities are the perfect space

Lynn decided her awareness campaigns should focus on university students because the students she reaches are the next generation of doctors, lawyers, politicians, and judges. “It is all about how we can educate the next generation.”

Most university or college students are going to progress in their careers and will be able to use their influence to educate the next generation. “But, most importantly, most of these students are going to become parents – and sooner or later one of them might become a parent to a bisexual, transgender, or gay child, and through my presentations it would have hopefully opened a lot for them to comprehend,” Lynn said. 

Lynn is internationally renowned for her transgender awareness work and advocacy, and her longstanding relationship with CGAS widened the scope to intensify this project. “Jessica’s work is very important, firstly because of her affiliation with the Kinsey Institute, but most importantly her work in transgender identity,” Dr Lake said. Lynn has presented classes, seminars and talks at some of the leading universities around the globe and in South Africa has delivered talks at the UFS and Rhodes University.

• The Department of Social Work at the UFS will host a Gender Diversity, Inclusion and Belonging Seminar with Jessica Lynn on 2 September 2022. Click here for more information. 

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept